Fentanyl

Generic Name
Fentanyl
Brand Names
Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent
Drug Type
Small Molecule
Chemical Formula
C22H28N2O
CAS Number
437-38-7
Unique Ingredient Identifier
UF599785JZ
Background

Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.

Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.

Fentanyl was FDA approved in 1968.

Indication

Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.

Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.

Associated Conditions
Cancer Related Pain (Breakthrough Pain), Severe, Chronic Pain
Associated Therapies
Anesthetic premedication therapy, Anesthetics Agent, General Anesthesia, Induction of anesthesia therapy, Maintenance of anesthesia therapy, Regional Anesthesia therapy

Analgesic Effect of Perineural Fentanyl Additive to Local Anesthetics in Femoral Nerve Block

Not Applicable
Conditions
Interventions
First Posted Date
2015-01-06
Last Posted Date
2016-07-27
Lead Sponsor
Chonnam National University Hospital
Target Recruit Count
100
Registration Number
NCT02331576
Locations
🇰🇷

Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea, Republic of

Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery

First Posted Date
2014-12-29
Last Posted Date
2014-12-29
Lead Sponsor
Hillel Yaffe Medical Center
Target Recruit Count
30
Registration Number
NCT02326727
Locations
🇮🇱

Hillel Yaffe Medical Center, Hadera, Israel

Post-Operative Pain Control in Opioid Tolerant Patients: Fentanyl Challenge Protocol Versus Standard of Care

Phase 4
Withdrawn
Conditions
Interventions
First Posted Date
2014-12-24
Last Posted Date
2015-11-01
Lead Sponsor
Bassett Healthcare
Registration Number
NCT02324933
Locations
🇺🇸

Bassett Healthcare Network, Cooperstown, New York, United States

Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

First Posted Date
2014-12-11
Last Posted Date
2017-01-04
Lead Sponsor
Kocaeli University
Target Recruit Count
148
Registration Number
NCT02314351
Locations
🇹🇷

Kocaeli University, Faculty of Medicine, Kocaeli, Turkey

Comparison of Regimens MPIB, CIPCEA, PCEA

First Posted Date
2014-10-30
Last Posted Date
2024-10-09
Lead Sponsor
KK Women's and Children's Hospital
Target Recruit Count
839
Registration Number
NCT02278601
Locations
🇸🇬

KK Women's and Children's Hospital, Singapore, Singapore

Intrathecal Hydromorphone for Labor Analgesia

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2014-10-29
Last Posted Date
2022-03-18
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
21
Registration Number
NCT02277782
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Opioid Effects on Cognitive Function Following Colonoscopy

First Posted Date
2014-10-17
Last Posted Date
2016-06-29
Lead Sponsor
Perihan Ekmekçi
Target Recruit Count
150
Registration Number
NCT02267681
Locations
🇹🇷

Ufuk University Dr Rıdvan Ege Hospital, Ankara, Turkey

Can Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2014-09-30
Last Posted Date
2015-01-09
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
21
Registration Number
NCT02252458
Locations
🇨🇭

Department of Anesthesia, University of Basel Hospital, Basel, Switzerland

© Copyright 2024. All Rights Reserved by MedPath